Forum Financial Management, LP Amgen Inc Transaction History

Forum Financial Management, LP

$5.24 Billion
Q3 2024

A detailed history of Forum Financial Management, LP transactions in Amgen Inc stock. As of the latest transaction made, Forum Financial Management, LP holds 350,373 shares of AMGN stock, worth $91.5 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares

350,373

Previous 350,824 0.13%

Holding current value

$91.5 Million

Previous $110 Million 2.99%

% of portfolio

2.15%

Previous 2.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $139,530 - $152,158	-451 Reduced 0.13%	350,373 $113 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $199,164 - $242,036	758 Added 0.22%	350,824 $110 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $45,707 - $55,175	170 Added 0.05%	350,066 $99.5 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $692,179 - $780,861	-2,707 Reduced 0.77%	349,896 $101 Million
Q3 2023 Nov 03, 2023	SELL	$218.65 - $271.46 $107,575 - $133,558	-492 Reduced 0.14%	352,603 $94.8 Million
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $339,403 - $401,338	1,584 Added 0.45%	353,095 $78.4 Million
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $51,705 - $63,020	-229 Reduced 0.07%	351,511 $85 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $27.8 Million - $35.4 Million	-121,543 Reduced 25.68%	351,740 $0
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $107,740 - $121,512	-480 Reduced 0.1%	473,283 $107 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $159,420 - $177,407	691 Added 0.15%	473,763 $115 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1,754 - $1,940	-8 Reduced -0.0%	473,072 $114 Million
Q4 2021 Feb 18, 2022	BUY	$198.88 - $227.6 $94.1 Million - $108 Million	473,080 New	473,080 $106 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forum Financial Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Forum Financial Management, LP with notifications on news.

Account

Forum Financial Management, LP Amgen Inc Transaction History